← back to search

Zhe Wang

Zhongda Hospital Southeast University · CN
Area of research
Molecular Biology · Cancer Research
Research interest
Research interests include Cancer-related molecular mechanisms research, RNA modifications and cancer, Ferroptosis and cancer prognosis, and Cancer-related gene regulation.
h-index
36
citations
4,571
works
296
NIH funding
primary concept
email

Recent publications

[Observation on the efficacy of the "page-turning" method for superior pancreatic border lymph node dissection in laparoscopic radical gastrectomy for gastric cancer].
PubMed 2025cited by 0position: firstdoi
Integrated analysis of single-cell RNA-seq and bulk RNA-seq reveals <i>MMP</i> mediated expression patterns by distinct tumor microenvironment immune profiles in cervical cancer
Journal of Cancer 2024cited by 6position: lastdoi
Effects of HOX family regulator-mediated modification patterns and immunity characteristics on tumor-associated cell type in endometrial cancer
Molecular Biomedicine 2024cited by 5position: lastdoi
The prognostic value of vascular endothelial growth factor in endometrial cancer: A protocol for systematic review and meta-analysis
Medicine 2024cited by 2position: middledoi
Development and applications of mRNA treatment based on lipid nanoparticles
Biotechnology Advances 2023cited by 55position: firstdoi
Role of macrophages in pulmonary arterial hypertension
Frontiers in Immunology 2023cited by 52position: middledoi
Application of artificial intelligence for improving early detection and prediction of therapeutic outcomes for gastric cancer in the era of precision oncology.
2023cited by 50position: contributordoi
Efficacy, safety, tolerability, and pharmacokinetics of long-acting injectable cabotegravir for HIV pre-exposure prophylaxis in transgender women: a secondary analysis of the HPTN 083 trial
The Lancet HIV 2023cited by 11position: middledoi
Clinical Genetic Features and Neoadjuvant Chemotherapy Response in HER2-Low Breast Cancers: A Retrospective, Multicenter Cohort Study
Annals of Surgical Oncology 2023cited by 11position: middledoi
Recent advances of long non-coding RNAs in control of hepatic gluconeogenesis
Frontiers in Endocrinology 2023cited by 6position: firstdoi
One-stage VATS surgery for synchronous bilateral lung lesion: a safe and feasible procedure
Journal of Cardiothoracic Surgery 2023cited by 3position: firstdoi
ASO Visual Abstract: Clinical Genetic Features and Neoadjuvant Chemotherapy Response in HER2-Low Breast Cancers—A Retrospective, Multicenter Cohort Study
Annals of Surgical Oncology 2023cited by 0position: middledoi
An all-in-one biomimetic iron-small interfering RNA nanoplatform induces ferroptosis for cancer therapy
Acta Biomaterialia 2022cited by 44position: middledoi
Single‐cell RNA sequencing reveals the characteristics of cerebrospinal fluid tumour environment in breast cancer and lung cancer leptomeningeal metastases
Clinical and Translational Medicine 2022cited by 34position: middledoi
Regulatory patterns analysis of transcription factor binding site clustered regions and identification of key genes in endometrial cancer
Computational and Structural Biotechnology Journal 2022cited by 4position: middledoi
LncRNA BDNF-AS as ceRNA regulates the miR-9-5p/BACE1 pathway affecting neurotoxicity in Alzheimer's disease
Archives of Gerontology and Geriatrics 2021cited by 54position: middledoi
Single-cell analysis reveals metastatic cell heterogeneity in clear cell renal cell carcinoma.
2021cited by 20position: contributordoi
Establishment and verification of a prognostic tumor microenvironment-based and immune-related gene signature in colon cancer.
2021cited by 2position: contributordoi
m<sup>6</sup>A regulator-based methylation modification patterns characterized by distinct tumor microenvironment immune profiles in colon cancer
Theranostics 2020cited by 260position: middledoi
FOXP3 promotes colorectal carcinoma liver metastases by evaluating MMP9 expression via regulating S-adenosylmethionine metabolism.
2020cited by 10position: contributordoi
Identification of seven-gene signature for prediction of lung squamous cell carcinoma.
2019cited by 37position: contributordoi
Prognostic and clinicopathological significance of long noncoding RNA CTD-2510F5.4 in gastric cancer.
2019cited by 32position: contributordoi
Systematic profiling of a novel prognostic alternative splicing signature in hepatocellular carcinoma.
2019cited by 10position: contributordoi
LncRNA LINC00163 upregulation suppresses lung cancer development though transcriptionally increasing TCF21 expression.
PubMed 2018cited by 31position: middle
Abstract A05: Genetic factors associated with racial disparities of liver cancer
Cancer Epidemiology Biomarkers & Prevention 2018cited by 0position: middledoi
Let-7e modulates the inflammatory response in vascular endothelial cells through ceRNA crosstalk
Scientific Reports 2017cited by 96position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Sanyuan Zhang · Shanxi Medical University3 papers (2024–2024)Xiaoyan Zhou · Fudan University2 papers (2023–2023) · 2 papers (2023–2023) · 2 papers (2023–2023)Huancheng Su · Shanxi Medical University2 papers (2024–2024)Yuqiong Liu · Zhengzhou University2 papers (2023–2023)Libo Yang · South China University of Technology2 papers (2023–2023)Dandan Han · University of Science and Technology of China2 papers (2023–2023)Huan Wan · South China Agricultural University2 papers (2023–2023)Wencai Li · Guangxi Medical University2 papers (2023–2023)Yueping Liu · Hebei Medical University2 papers (2023–2023)Shuangping Guo · Shandong University2 papers (2023–2023)Longlong Bao · Shanghai Medical College of Fudan University2 papers (2023–2023)Sha Fu · Sun Yat-sen University2 papers (2023–2023)Jiaolin Yang · Shanxi Medical University2 papers (2024–2024)Gang Chen · Wenzhou Medical University2 papers (2023–2023)Feng Ye · Sichuan University2 papers (2023–2023)Ting Wang · Shenzhen University1 papers (2022–2022)Weidong Wang · Panyu Hospital of Chinese Medicine1 papers (2025–2025)Lei Zhang · Ministry of Education of the People's Republic of China1 papers (2022–2022)